: This study aims to investigate the patterns of maternal sensitivity via structured and systematic observational methods among mothers from a disadvantaged community in Turkey. Background: Caregiving sensitivity is shaped by cultural parenting ethnotheories, and there is a need to examine in non-Western cultures to see its universal and culturally-specific features.: Ninety-eight mothers and their interactions with infants were videotaped during home-visits, and their caregiving behaviours were assessed via the Maternal Behaviour Q-Set.: Results of the Q-factor analysis revealed two distinct caregiving profiles. The first profile, 'sensitivity vs. insensitivity', describes mothers who were characterised by sensitive behaviours to their babies, and acceptance of their infant. Mothers in this group were more aware and responsive to their babies' needs and demands. The second profile, 'nonsynchronous vs. synchronous', describes mothers who showed noncontingent behaviours during interactions such as being unable to follow the pace of the infant or to respond to infants' needs on time.: This study contributes to the literature by showing that mothers from Turkey can be grouped in terms of sensitivity similar to the previous studies, although the descriptive behaviours of sensitivity may vary.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02646838.2020.1722803DOI Listing

Publication Analysis

Top Keywords

caregiving profiles
8
describes mothers
8
mothers
7
caregiving
4
profiles mothers
4
mothers economically
4
economically disadvantaged
4
disadvantaged sample
4
sample turkey
4
turkey observational
4

Similar Publications

Purpose: Cerebral palsy (CP) is the most prevalent motor disability affecting children. Many children with CP have significant speech difficulties and require augmentative and alternative communication (AAC) to participate in communication. Despite demonstrable benefits, the use of AAC systems among children with CP remains constrained, although research in Canada is lacking.

View Article and Find Full Text PDF

Borderline personality disorder (BPD) has a strong impact not only on patients' lives but also on their families. The presence of an invalidating environment is one of the key factors in the etiology of BPD. This study evaluated the impact of the Family connections (FC) program on burden, grief, and other clinical variables in 202 caregivers and identified the profiles of participants who improved/deteriorated their levels of burden and grief.

View Article and Find Full Text PDF

Although many parents worry that their child will be the target of racial profiling, there is a dearth of literature on how parental worries about children facing racism are linked to racial socialization (RS) practices and youth internalizing symptoms. Additionally, it is unclear how RS content relative to competency may uniquely influence whether and how parental worries influence youth internalizing outcomes. Using data from 203 Black parents (M = 44.

View Article and Find Full Text PDF

Aripiprazole 2-month ready-to-use (Ari 2MRTU) is a long-acting injectable antipsychotic that was approved for use in Europe in March 2024, for the maintenance treatment of schizophrenia in adult patients stabilized with aripiprazole; it is administered via gluteal intramuscular injection once every two months. This review examines population pharmacokinetic model-based simulations relevant to the use of Ari 2MRTU in Europe, accompanied by expert commentary that contextualizes the simulations and highlights the potential implications of the availability of Ari 2MRTU for patients, caregivers, and clinicians. Various simulations conducted across 8 weeks (representing the first dosing interval), or 32 weeks (representing maintenance dosing) demonstrated an aripiprazole exposure profile for Ari 2MRTU that was similar to aripiprazole once-monthly (AOM), but with an extended dosing interval.

View Article and Find Full Text PDF

Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps remain in advanced treatments for SCD. To help address this burden, Tanzania has established one of the largest single-centre SCD programmes in the world and developed an advanced therapy programme for SCD focused on patient engagement and advocacy, clinical activities involving exchange blood transfusion (ExBT) and haematopoietic stem cell transplant (HSCT), gene therapy (GT) preparedness, and enabling partnerships. This report describes the programme's genesis, structure and progress achieved.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!